Literature DB >> 24689889

Problems with using total serum bilirubin as a criterion for phototherapy in extremely low-birthweight infants.

Kenji Ichinomiya1, Fumitaka Inoue, Aya Koizumi, Takahiro Inoue, Toru Fujiu, Kenichi Maruyama.   

Abstract

BACKGROUND: Despite the early use of phototherapy and exchange transfusion in premature infants based on total serum bilirubin (TSB), the reemergence of kernicterus has been reported. The aim of this study was to assess the validity of using TSB as the criterion for phototherapy in extremely low-birthweight infants (ELBWI).
METHODS: We reviewed the medical charts of 43 ELBWI admitted to hospital between January 2009 and December 2010, and analyzed the relationship between TSB and unbound bilirubin (UB).
RESULTS: No infant underwent exchange transfusion or developed acute bilirubin encephalopathy. There was a significant correlation between TSB and UB measured immediately before phototherapy during the first 7 days of life (r = 0.657, P < 0.001), but none thereafter (r = 0.120, P = 0.213). Thirty-seven percent of infants who underwent phototherapy during the first 7 days of life had suprathreshold USB but subthreshold TSB, whereas this rose to 97% thereafter.
CONCLUSIONS: No correlation was observed between TSB and UB in ELBWI after the first 7 days of life, and almost all phototherapy sessions were initiated based on the UB criterion, even though TSB was below the accepted threshold. UB may be high if jaundice is evaluated solely on the basis of TSB.
© 2014 Japan Pediatric Society.

Entities:  

Keywords:  extremely low-birthweight infant; neonatal hyperbilirubinemia; phototherapy; total serum bilirubin; unbound bilirubin

Mesh:

Substances:

Year:  2014        PMID: 24689889     DOI: 10.1111/ped.12351

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  1 in total

1.  A Pilot Metabolic Profiling Study of Patients With Neonatal Jaundice and Response to Phototherapy.

Authors:  A Cai; S Qi; Z Su; H Shen; Y Yang; W Cai; Y Dai
Journal:  Clin Transl Sci       Date:  2016-06-15       Impact factor: 4.689

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.